GSK logo

GSK (GSK) Shareholders Equity

Annual Shareholders Equity

$17.00 B
+$4.18 B+32.57%

31 December 2023

GSK Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$18.75 B
+$567.94 M+3.12%

30 September 2024

GSK Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GSK Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+10.3%
3 y3 years-16.3%-7.7%
5 y5 years+13.7%+25.4%

GSK Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-16.3%+32.6%-11.8%+83.4%
5 y5 years-16.3%+32.6%-11.9%+83.4%
alltimeall time-16.3%>+9999.0%-13.5%>+9999.0%

GSK Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$18.75 B(+3.1%)
June 2024
-
$18.18 B(+4.0%)
Mar 2024
-
$17.47 B(+2.8%)
Dec 2023
$17.00 B(+32.6%)
$17.00 B(+6.1%)
Sept 2023
-
$16.02 B(+0.1%)
June 2023
-
$16.01 B(+9.3%)
Mar 2023
-
$14.64 B(+14.1%)
Dec 2022
$12.83 B(-36.9%)
$12.83 B(+25.5%)
Sept 2022
-
$10.22 B(-48.5%)
June 2022
-
$19.86 B(-6.6%)
Mar 2022
-
$21.26 B(+4.6%)
Dec 2021
$20.32 B(+2.2%)
$20.32 B(-1.9%)
Sept 2021
-
$20.71 B(-2.7%)
June 2021
-
$21.28 B(+4.2%)
Mar 2021
-
$20.43 B(+2.8%)
Dec 2020
$19.88 B(+32.9%)
$19.88 B(+8.2%)
Sept 2020
-
$18.38 B(+9.8%)
June 2020
-
$16.73 B(+3.3%)
Mar 2020
-
$16.20 B(+8.3%)
Dec 2019
$14.95 B(+211.7%)
$14.95 B(+3.3%)
Sept 2019
-
$14.47 B(+215.9%)
June 2019
-
$4.58 B(-12.5%)
Mar 2019
-
$5.24 B(+9.1%)
Dec 2018
$4.80 B(-5320.9%)
$4.80 B(-17.7%)
Sept 2018
-
$5.83 B(+21.2%)
June 2018
-
$4.81 B(-5073.9%)
Mar 2018
-
-$96.70 M(+5.2%)
Dec 2017
-$91.90 M(-106.7%)
-$91.90 M(-105.3%)
Sept 2017
-
$1.74 B(+64.7%)
June 2017
-
$1.06 B(-50.7%)
Mar 2017
-
$2.14 B(+54.9%)
Dec 2016
$1.38 B(-81.8%)
$1.38 B(+671.9%)
Sept 2016
-
$178.89 M(-76.8%)
June 2016
-
$772.70 M(-80.9%)
Mar 2016
-
$4.04 B(-46.7%)
Dec 2015
$7.58 B(+14.2%)
$7.58 B(-7.9%)
Sept 2015
-
$8.23 B(-23.3%)
June 2015
-
$10.72 B(-2.6%)
Mar 2015
-
$11.01 B(+65.9%)
Dec 2014
$6.64 B(-42.5%)
$6.64 B(-19.0%)
Sept 2014
-
$8.19 B(-21.4%)
June 2014
-
$10.42 B(-5.4%)
Mar 2014
-
$11.01 B(-4.6%)
Dec 2013
$11.54 B(+23.1%)
$11.54 B(+19.5%)
Sept 2013
-
$9.66 B(-1.3%)
June 2013
-
$9.78 B(-3.8%)
Mar 2013
-
$10.17 B(+8.5%)
Dec 2012
$9.37 B(-24.3%)
$9.37 B(-7.2%)
Sept 2012
-
$10.10 B(-7.7%)
June 2012
-
$10.94 B(-21.9%)
Mar 2012
-
$14.00 B(+13.1%)
Dec 2011
$12.38 B(-9.8%)
$12.38 B(+6.6%)
Sept 2011
-
$11.61 B(-16.8%)
June 2011
-
$13.95 B(-4.3%)
Mar 2011
-
$14.58 B(+6.3%)
Dec 2010
$13.72 B(-15.2%)
$13.72 B(-11.5%)
Sept 2010
-
$15.49 B(+18.2%)
June 2010
-
$13.10 B(-19.1%)
Mar 2010
-
$16.20 B(+0.1%)
DateAnnualQuarterly
Dec 2009
$16.18 B(+39.3%)
$16.18 B(+9.0%)
Sept 2009
-
$14.85 B(+16.9%)
June 2009
-
$12.70 B(+9.8%)
Mar 2009
-
$11.57 B(-0.4%)
Dec 2008
$11.62 B(-39.1%)
$11.62 B(-12.9%)
Sept 2008
-
$13.34 B(-10.0%)
June 2008
-
$14.82 B(-16.2%)
Mar 2008
-
$17.69 B(-7.3%)
Dec 2007
$19.09 B(+3.9%)
$19.09 B(-5.5%)
Sept 2007
-
$20.20 B(-6.8%)
June 2007
-
$21.68 B(+10.9%)
Mar 2007
-
$19.55 B(+6.4%)
Dec 2006
$18.38 B(+46.2%)
$18.38 B(+7.1%)
Sept 2006
-
$17.15 B(+5.3%)
June 2006
-
$16.29 B(+6.3%)
Mar 2006
-
$15.32 B(+21.9%)
Dec 2005
$12.57 B(+11.5%)
$12.57 B(+2.6%)
Sept 2005
-
$12.25 B(+7.0%)
June 2005
-
$11.45 B(-0.3%)
Mar 2005
-
$11.48 B(+1.8%)
Dec 2004
$11.28 B(-18.2%)
$11.28 B(+25.5%)
Sept 2004
-
$8.99 B(-4.7%)
June 2004
-
$9.42 B(+17.9%)
Mar 2004
-
$7.99 B(-42.0%)
Dec 2003
$13.79 B(+30.0%)
$13.79 B(+54.5%)
Sept 2003
-
$8.92 B(-29.9%)
June 2003
-
$12.74 B(+12.5%)
Mar 2003
-
$11.32 B(+6.7%)
Dec 2002
$10.61 B(-2.8%)
$10.61 B(+4.2%)
Sept 2002
-
$10.18 B(-1.7%)
June 2002
-
$10.36 B(-0.8%)
Mar 2002
-
$10.44 B(-4.3%)
Dec 2001
$10.91 B(-5.1%)
$10.91 B(-11.6%)
Sept 2001
-
$12.34 B(+5.1%)
June 2001
-
$11.74 B(+4.8%)
Mar 2001
-
$11.20 B(-2.6%)
Dec 2000
$11.50 B(+126.4%)
$11.50 B(+13.6%)
Sept 2000
-
$10.12 B(+5.2%)
June 2000
-
$9.62 B(-0.7%)
Mar 2000
-
$9.69 B(+90.8%)
Dec 1999
$5.08 B(+13.6%)
$5.08 B(+2.6%)
June 1999
-
$4.95 B(+10.8%)
Dec 1998
$4.47 B(+46.4%)
$4.47 B(+19.3%)
June 1998
-
$3.75 B(+22.8%)
Dec 1997
$3.05 B(+46.6%)
$3.05 B(+46.6%)
Dec 1996
$2.08 B(+1374.8%)
$2.08 B(+218.0%)
Dec 1995
$141.16 M(-78.4%)
-
June 1995
-
$654.72 M(-91.5%)
June 1995
$654.72 M(-91.5%)
-
June 1994
$7.74 B(+12.9%)
$7.74 B(+12.9%)
June 1993
$6.86 B(+1.1%)
$6.86 B(+1.1%)
June 1992
$6.79 B(+30.4%)
$6.79 B(+30.4%)
June 1991
$5.20 B(+9.3%)
$5.20 B(+9.3%)
June 1990
$4.76 B(+34.1%)
$4.76 B(+34.1%)
June 1989
$3.55 B(+16.5%)
$3.55 B(+16.5%)
June 1988
$3.05 B(+30.6%)
$3.05 B(+30.6%)
June 1987
$2.33 B(+39.9%)
$2.33 B(+39.9%)
June 1986
$1.67 B(+56.0%)
$1.67 B
June 1985
$1.07 B(+17.0%)
-
June 1984
$913.95 M
-

FAQ

  • What is GSK annual stockholders equity?
  • What is the all time high annual shareholders equity for GSK?
  • What is GSK quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for GSK?
  • What is GSK quarterly shareholders equity year-on-year change?

What is GSK annual stockholders equity?

The current annual shareholders equity of GSK is $17.00 B

What is the all time high annual shareholders equity for GSK?

GSK all-time high annual stockholders equity is $20.32 B

What is GSK quarterly stockholders equity?

The current quarterly shareholders equity of GSK is $18.75 B

What is the all time high quarterly shareholders equity for GSK?

GSK all-time high quarterly stockholders equity is $21.68 B

What is GSK quarterly shareholders equity year-on-year change?

Over the past year, GSK quarterly stockholders equity has changed by +$1.74 B (+10.25%)